Featured Research

from universities, journals, and other organizations

Collaborative Research Provides New Information About Interleukin-12's Role In Angiogenesis

Date:
July 27, 1998
Source:
Wistar Institute
Summary:
Interleukin-12 (IL-12), a cytokine discovered at The Wistar Institute in the mid-1980s, is known to engage in potent anti-tumor activities. Until recently, however, the biological events governing its behavior were little understood.

PHILADELPHIA, Penn. -- Interleukin-12 (IL-12), a cytokine discovered at The Wistar Institute in the mid-1980s, is known to engage in potent anti-tumor activities. Until recently, however, the biological events governing its behavior were little understood.

New information about IL-12, unearthed by scientists working in the laboratories of Dr. Giorgio Trinchieri at Wistar and Dr. William M.F. Lee at the University of Pennsylvania, will appear in the July 24 issue of Immunity.

IL-12 provokes a series of events that ultimately interfere with angiogenesis, or the formation of blood vessels that nourish and enlarge tumors. Without angiogenesis, tumors cannot thrive.

"Our findings suggest that tumor cells may have an inherent ability to produce their own antiangiogenic elements," explains Dr. Trinchieri, "and that cytokine therapy may enhance the spontaneous production of these factors. This understanding may help scientific investigators plan new therapeutic approaches to cancer."

IL-12 triggers the production of a protein, interferon-gamma (IFN- ), which in turn leads to the manufacture of a chemokine, IP-10, which blocks tumor-induced angiogenesis. To produce IP-10, however, IFN- must be able to interact directly with the tumor cells. And, if those tumor cells are genetically altered in a way that prevents them from being receptive to IFN- , their ability to hinder blood vessel formation is destroyed.

According to Dr. Trinchieri, "the ability of tumor cells to induce angiogenesis is well known, but their ability to produce antiangiogenic factors is a new finding that helps shed light on the mechanisms of anticancer therapy."

The Wistar Institute, established in 1892, was the first independent medical research facility in the country. For more than 100 years, Wistar scientists have been making history and improving world health through their development of vaccines for diseases that include rabies, German measles, infantile gastroenteritis (rotavirus), and cytomegalovirus; discovery of molecules like interleukin-12, which are helping the immune system fight bacteria, parasites, viruses and cancer; and location of genes that contribute to the development of diseases like breast, lung and prostate cancer. Wistar is a National Cancer Institute Cancer Center.


Story Source:

The above story is based on materials provided by Wistar Institute. Note: Materials may be edited for content and length.


Cite This Page:

Wistar Institute. "Collaborative Research Provides New Information About Interleukin-12's Role In Angiogenesis." ScienceDaily. ScienceDaily, 27 July 1998. <www.sciencedaily.com/releases/1998/07/980727080220.htm>.
Wistar Institute. (1998, July 27). Collaborative Research Provides New Information About Interleukin-12's Role In Angiogenesis. ScienceDaily. Retrieved September 2, 2014 from www.sciencedaily.com/releases/1998/07/980727080220.htm
Wistar Institute. "Collaborative Research Provides New Information About Interleukin-12's Role In Angiogenesis." ScienceDaily. www.sciencedaily.com/releases/1998/07/980727080220.htm (accessed September 2, 2014).

Share This




More Health & Medicine News

Tuesday, September 2, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Snack Attack: Study Says Action Movies Make You Snack More

Snack Attack: Study Says Action Movies Make You Snack More

Newsy (Sep. 2, 2014) You're more likely to gain weight while watching action flicks than you are watching other types of programming, says a new study published in JAMA. Video provided by Newsy
Powered by NewsLook.com
U.N. Says Ebola Travel Restrictions Will Cause Food Shortage

U.N. Says Ebola Travel Restrictions Will Cause Food Shortage

Newsy (Sep. 2, 2014) The U.N. says the problem is two-fold — quarantine zones and travel restrictions are limiting the movement of both people and food. Video provided by Newsy
Powered by NewsLook.com
Get on Your Bike! London Cycling Popularity Soars Despite Danger

Get on Your Bike! London Cycling Popularity Soars Despite Danger

AFP (Sep. 1, 2014) Wedged between buses, lorries and cars, cycling in London isn't for the faint hearted. Nevertheless the number of people choosing to bike in the British capital has doubled over the past 15 years. Duration: 02:27 Video provided by AFP
Powered by NewsLook.com
Can You Train Your Brain To Eat Healthy?

Can You Train Your Brain To Eat Healthy?

Newsy (Sep. 1, 2014) New research says if you condition yourself to eat healthy foods, eventually you'll crave them instead of junk food. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins